South African Psychiatry - November 2018

ANNOUNCEMENT
CELEBRATES
60 YEARS IN MENTAL HEALTH
In 2018, we proudly mark the 60th year of
Janssen’s continued dedication to the area
of mental health. Our journey began in 1958,
with Dr Paul Janssen’s discovery of a pioneering
antipsychotic drug, haloperidol, challenging the
tradition of institutionalisation. Since then, we
have continued our mission to reduce the burden,
disability and devastation caused by mental
health disorders, by understanding and producing
treatments that address the most serious unmet
medical needs. We recognise the importance of
continuous treatment and that non-adherence is a
consistent feature of schizophrenia, which is why we
consistently pursue the development of long acting
formulations of our most prominent antipsychotic
treatments.
medicines 2 – which have collectively helped to
shape the care of neuropsychiatric diseases.
Mental health affects us all – one in four people
in the world will be affected by mental health or
mood disorders at some point in their lives 3 – and
we celebrate this legacy in the knowledge that we
remain steadfast in our commitment to transforming
and improving individual lives.
Over the last 60 years we have produced more than
20 medications and innovations 1 – two of which are
on the World Health Organization’s list of essential
1 Awouters F.H.L., Lewi P.J. Forty Years of Antipsychotic Drug Research – from Haloperidol to Paliperidone – with Dr. Paul Janssen. Antipsychotic
drug research 2007;57(10):625–632
2 World Health Organization. Model Lists of Essential Medicines. Available at: http://www.who.int/selection_medicines/committees/expert/20/
EML_2015_FINAL_amended_AUG2015.pdf?ua=1. Accessed May 2018.
3 World Health Organization. http://www.who.int/whr/2001/media_centre/press_release/en/
PROUDLY
22 * SOUTH AFRICAN PSYCHIATRY ISSUE 17 2018